Jackob Moskovitz

Jackob Moskovitz

Mar 12, 2019

Group 6 Copy 18
0
    Please wait...

    About This Project

    Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we make anesthesia for dogs safer with the help of nutrition?

    Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

    Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

    Artisanal fishermen risk their lives every day to support their families and communities. Using outdated...

    Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to...

    Campaign Ended

    A medicine project funded by 45 people